Stocks · Technology · Laboratory Analytical Instruments

EyePoint, Inc.

EYPT Clue Score33
United States Fiscal year ends December CIK 0001314102 Results filed 19 Oct 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Karen L. Zaderej
18 Aug 2026
Director
Buy
10,600
$4.93
$52.26K
Jay S. Duker
16 Mar 2026
President and CEO
Buy indirect
1,500
$13.15
$19.72K
Karen L. Zaderej
19 May 2025
Director
Buy
5,000
$5.99
$29.95K
Karen L. Zaderej
16 May 2025
Director
Buy
5,000
$5.81
$29.05K
Karen L. Zaderej
15 May 2025
Director
Buy
5,000
$5.47
$27.35K
Karen L. Zaderej
14 May 2025
Director
Buy
5,000
$5.42
$27.10K
Goran Ando
21 Aug 2024
Director
Buy
5,000
$7.95
$39.75K
Wendy F Dicicco
20 Aug 2024
Director
Buy
2,567
$7.79
$20.00K
Karen L. Zaderej
19 Aug 2024
Director
Buy
12,500
$7.98
$99.75K
Nancy Lurker
16 Aug 2024
Director
Buy
3,173
$7.88
$25.00K
Cormorant Asset Management, LP
6 May 2024
10% owner
Buy indirect
207,153
$12.36
$2.56M
Cormorant Asset Management, LP
6 May 2024
10% owner
Buy indirect
642,847
$11.70
$7.52M
Cormorant Asset Management, LP
18 Apr 2024
10% owner
Buy indirect
186,521
$18.90
$3.53M
Cormorant Asset Management, LP
18 Apr 2024
10% owner
Buy indirect
395,244
$17.62
$6.96M
Cormorant Asset Management, LP
11 Jan 2024
10% owner
Buy indirect
750,000
$19.75
$14.81M
Cormorant Asset Management, LP
9 Jan 2024
10% owner
Buy indirect
105,000
$21.32
$2.24M
Cormorant Asset Management, LP
8 Dec 2023
10% owner
Buy indirect
588,235
$17.00
$10.00M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
8,260
$34.49
$284.89K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
19,866
$33.75
$670.48K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
41,824
$33.08
$1.38M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
86,713
$31.83
$2.76M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
15,582
$30.74
$478.99K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
18,601
$29.91
$556.36K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
8,168
$28.78
$235.08K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
27,425
$27.87
$764.33K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
53,109
$26.73
$1.42M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
65,086
$25.88
$1.68M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
39,899
$24.87
$992.29K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
37,081
$24.01
$890.31K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
28,090
$22.80
$640.45K
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
79,805
$21.87
$1.75M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
122,625
$20.62
$2.53M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
945,664
$19.88
$18.80M
Cormorant Asset Management, LP
4 Dec 2023
10% owner
Buy indirect
321,259
$18.80
$6.04M
Michael Craig Pine
14 Mar 2022
Chief Corp Dev.&Strat. Officer
Buy
1,000
$12.21
$12.21K
George Elston
4 Sep 2020
Chief Financial Officer
Buy
10,000
$0.48
$4.80K
George Elston
24 Aug 2020
Chief Financial Officer
Buy
10,000
$0.61
$6.11K
George Elston
12 Mar 2020
Chief Financial Officer
Buy
10,000
$0.96
$9.60K
Nancy Lurker
10 Mar 2020
President & CEO
Buy
98,000
$1.06
$104.03K
George Elston
15 Nov 2019
Chief Financial Officer
Buy
10,000
$1.43
$14.29K
John B. Landis
13 May 2019
Director
Buy
40,000
$1.74
$69.60K
Jay S. Duker
1 Apr 2019
Director
Buy
5,000
$1.89
$9.45K
Douglas Evan Godshall
29 Mar 2019
Director
Buy
17,000
$1.75
$29.78K
Nancy Lurker
29 Mar 2019
President & CEO
Buy
28,500
$1.76
$50.25K
EW Healthcare Partners, L.P.
25 Jun 2018
10% owner
Buy indirect
652,244
$1.27
$825.09K
EW Healthcare Partners, L.P.
25 Jun 2018
10% owner
Buy
16,211,822
$1.27
$20.51M
EW Healthcare Partners, L.P.
28 Mar 2018
10% owner
Buy indirect
332,863
$1.10
$366.15K
EW Healthcare Partners, L.P.
28 Mar 2018
10% owner
Buy
8,273,461
$1.10
$9.10M
Nancy Lurker
14 Jun 2017
President and CEO
Buy
56,700
$1.76
$99.96K

What was left out

Form 4 filings counted 312
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 3,676,102
Sales filed before the plan box existed 1
History held since 22 Oct 2007